Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation.

Autor: Tada A; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Minami T; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan. Electronic address: to-minami@hyo-med.ac.jp., Kitai H; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Higashiguchi Y; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Tokuda M; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Higashiyama T; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Negi Y; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Horio D; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Nakajima Y; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Otsuki T; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Mikami K; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Takahashi R; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Nakamura A; Department of Thoracic Surgery, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Kitajima K; Department of Radiology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Ohmuraya M; Department of Genetics, Hyogo Medical University, Nishinomiya, Japan., Kuribayashi K; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan., Kijima T; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Hyogo, Japan; Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Hyogo, Japan.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jun; Vol. 180, pp. 107219. Date of Electronic Publication: 2023 Apr 26.

546P Combination therapy with anti-PD-1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation

Autor: Minami, T. ¹, Tada, A. ², Kitai, H. ², Fujioka, T. ², Kawamura, N. ², Kondo, T. ², Murakami, M. ², Morishita, M. ², Tokuda, M. ², Higashiyama, T. ², Negi, Y. ², Horio, D. ², Otsuki, T. ², Mikami, K. ¹, Takahashi, R. ¹, Kuribayashi, K. ², Kijima, T. ²

Publikováno v: In Annals of Oncology November 2023 34 Supplement 4:S1683-S1683

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.